Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement science

This article was originally published in The Tan Sheet

Executive Summary

A healthy diet with adequate amounts of fruits and vegetables is more advisable than taking vitamin or mineral supplements, suggests a report entitled "Vitamins and Minerals: Does the Epidemiological Evidence Justify General Supplementation." Released by the American Council on Science & Health in February, the report concludes, "while intriguing and encouraging, the scientific evidence to date does not provide a firm basis for advocating dietary supplementation in normal, healthy adults to prevent chronic diseases such as cancer and heart disease." One exception the 41-page report makes is for calcium's efficacy in decreasing the risk of osteoporosis in women. The report also examines B vitamins and heart disease as well as antioxidants and cancer, heart disease and age-related macular degeneration

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel